Medicure EBIT per Share
The EBIT per Share of Medicure (MPH.V) as of Oct 18, 2026 is -0.66 CAD. In the previous year, EBIT per Share was -0.26 CAD — a change of 151.66% (lower).
Get this data via API
Financial Data API
EBIT per Share
-0.66CAD
YoY
151.66%
Last updated:
The Medicure EBIT per Share history
3 Years
10 Years
25 Years
Max
| YEAR | EBIT per Share | YoY |
|---|---|---|
| est | -0.36CAD | +33.37% |
| est | -0.27CAD | -12.92% |
| est | -0.31CAD | +3.34% |
| est | -0.30CAD | +3.45% |
| est | -0.29CAD | -208.84% |
| est | 0.27CAD | -166.59% |
| est | -0.40CAD | -39.44% |
| -0.66CAD | +151.66% | |
| -0.26CAD | +220.49% | |
| -0.08CAD | -170.32% | |
| 0.12CAD | -307.84% | |
| -0.06CAD | -92.12% | |
| -0.71CAD | -0.62% | |
| -0.72CAD | +821.13% | |
| -0.08CAD | -133.25% | |
| 0.23CAD | -47.57% | |
| 0.45CAD | +27.03% | |
| 0.35CAD | +336.20% | |
| 0.08CAD | +521.73% | |
| 0.01CAD | -107.56% | |
| -0.17CAD | -20,776.99% | |
| 0.00CAD | -100.58% | |
| -0.14CAD | -64.41% | |
| -0.40CAD | -49.87% | |
| -0.80CAD | -83.25% | |
| -4.81CAD | +14.33% | |
| -4.20CAD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Medicure Stock analysis
Frequently Asked Questions about Medicure stock
EBIT per Share of Medicure is -0.66 CAD in 2025.
EBIT per Share of Medicure changed from -0.26 CAD to -0.66 CAD, representing a 151.66% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Medicure since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Medicure
All Key Metrics — Medicure
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth